Market Scope Market Dynamics Drivers Burgeoning demand for potent metabolic therapies The rising cases of type 2 diabetes and obesity in Australia, growing trend of early diagnosis for timely interventions, changing lifestyles and the need for effective treatment strategies to lower the disease burden and improving patient health outcomes are boosting the demand for GLP-1 receptor agonists in Australia
Influencers and biohackers promote unverified compounds like SLU-PP-332 as "exercise mimetics," despite the lack of human safety data
DOI: 10.1001/jamanetworkopen.2026.12133,
Its well organised, family-friendly, and all the staff we encountered were super helpful and friendly
Consequently, targeting ferroptosis presents a promising therapeutic approach, with traditional Chinese medicine (TCM) showing particular potential through its multi-dimensional and holistic mechanisms
Existing evidence suggests that GLP-1RAs may influence binge-eating symptoms and eating-disorder-related psychopathology, but the effects are heterogeneous and depend strongly on study design, behavioural context, and patient phenotype
